Shanghai Qiangyao Biotechnology Co., Ltd. (ChinaPeptides / QYAOBIO)

Shanghai QYAOBIO Co., Ltd. (ChinaPeptides/QYAOBIO), founded in October 2008, is a technology-based enterprise focusing on peptide synthesis, protein expression, and antibody preparation. In China, peptide solid phase synthesis (SPPs) technology was adopted earlier. The company maturely mastered 300 + peptide special modification core technologies, and has branches and scientific research laboratories in Suzhou, Wuhan, and Ezhou; cumulatively serving more than 50,000 customers worldwide, covering more than 50 countries and China's Hong Kong, Macao, and Taiwan regions, of which more than 90% are biomedical research institutions and pharmaceutical companies such as universities, hospitals, laboratories, and research institutes. Has passed ISO 9001: 2015 quality system certification, > 99% peptide synthesis success rate, provide HPLC/MS report and optional endotoxin/salt type test, as soon as 3 days delivery; core business is peptide synthesis, protein expression and antibody preparation.

Shanghai Qiangyao Biotechnology Co., Ltd. (ChinaPeptides / QYAOBIO) is located at Room 1304, No. 8, Shanghaipudongxinquchuansha Road Nonglousuzhouwujiangquyunchuang Road Shanghuidashawuhandonghugaoxinqugaoxin Avenue Beidou Road Haochanyejididong, China.

Main peptides produced: Epitalon, BPC-157, GHK-Cu, MOTS-c, Semax, TB-500 (Thymosin Beta-4).

Finished peptide dosage forms available (lyophilised powder for injection).

Website: https://www.chinapeptides.com